Nu Eyne Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Nu Eyne General Information

Description

Developer of a medical device designed to focus on treating ophthalmological disorders. The company's device mimics the innate biological signal to induce efficient and proper healing of damaged tissues and nerves and uses tissue engineering and neuromodulation technology to treat dry eye syndrome and eye pain, enabling medical practitioners to cure optical disorders with ease.

Contact Information

Website
www.nueyne.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 608, Mario Tower, 28
  • Digital-ro 30-gil, Guro-gu
  • Seoul
  • South Korea
+82
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Corporate Office
  • Room 608, Mario Tower, 28
  • Digital-ro 30-gil, Guro-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nu Eyne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC 01-Feb-2024 Completed Generating Revenue
9. Secondary Transaction - Private 25-Sep-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Jul-2022 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Later Stage VC (Series C) 01-Aug-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Feb-2020 Completed Product Development
4. Early Stage VC (Series A) 11-Nov-2018 Completed Product Development
3. Accelerator/Incubator 08-Dec-2017 $137K $577K Completed Product Development
2. Accelerator/Incubator 01-Nov-2017 $441K Completed Startup
To view Nu Eyne’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nu Eyne Patents

Nu Eyne Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1121835-S1 Goggle type massaging device Active 29-Nov-2024
US-20260048262-A1 Neuromodulation device associated with sleep cycle Inactive 14-Aug-2024
US-20260041911-A1 Low frequency electrode treatment device Pending 12-Aug-2024
US-20240108406-A1 Renal denervation catheter Inactive 05-Apr-2021
WO-2022215760-A1 Renal denervation catheter Inactive 05-Apr-2021 A61B18/1492
To view Nu Eyne’s complete patent history, request access »

Nu Eyne Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nu Eyne Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yozma Group Korea Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
COMEUP STARS Accelerator/Incubator
Compa Ventures Venture Capital Minority
Open water Investment Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Nu Eyne FAQs

  • When was Nu Eyne founded?

    Nu Eyne was founded in 2017.

  • Where is Nu Eyne headquartered?

    Nu Eyne is headquartered in Seoul, South Korea.

  • What is the size of Nu Eyne?

    Nu Eyne has 11 total employees.

  • What industry is Nu Eyne in?

    Nu Eyne’s primary industry is Therapeutic Devices.

  • Is Nu Eyne a private or public company?

    Nu Eyne is a Private company.

  • What is Nu Eyne’s current revenue?

    The current revenue for Nu Eyne is .

  • How much funding has Nu Eyne raised over time?

    Nu Eyne has raised $18.9M.

  • Who are Nu Eyne’s investors?

    Yozma Group Korea, MedTech Innovator, COMEUP STARS, Compa Ventures, and Open water Investment are 5 of 9 investors who have invested in Nu Eyne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process